Press releases

06 August 2015

‘Socially Responsible Health Economy Day”: minister for social affairs visits REBIRTH

In preparation for the second major Master Plan Conference in November 2015, Lower Saxony’s minister for social affairs and health, Cornelia Rundt, visited the REBIRTH Cluster of Excellence at Hannover Medical School (MHH) on 6... [more]

09 March 2015

Now with added pressure: study on aortic heart valves that last a lifetime

In Europe, 65,000 aortic valves are replaced to treat acquired or congenital diseases of the heart valve every year. The European Union (EU) is supporting the clinical trial on ‘Aortic Valve Replacement using Individualised... [more]

02 March 2015

Foundation for innovative (blood) cell transplantation

Human blood consists of a variety of different blood cells, each with specific jobs. If, however, blood formation is adversely affected (as in leukaemia) or unable to keep pace with demand (as when major injuries occur),... [more]

13 January 2015

Repairing diseased hearts: REBIRTH researchers discover protein in bone marrow

Scientists at Hannover Medical School (MHH) have discovered a protein in the bone marrow cells of heart attack patients that stimulates healing of the cardiac muscle and can protect against persistent myocardial insufficiency.... [more]

10 December 2014

REBIRTH researchers produce large quantities of cardiac muscle cells from stem cells

Heart attacks or cardiac insufficiency often result in irreparable damage to the cardiac muscle tissue. Many patients could be helped by tissue produced in the lab. However, in order to be able to engineer heart tissue from human... [more]

26 November 2014

REBIRTH research: Hereditary Prince of Hannover and Region President impressed

Distinguished visitors at MHH: Ernst August, Hereditary Prince of Hannover, Duke of Brunswick and Lüneburg, joined Hauke Jagau, president of the Region Hannover authority, for a tour of the REBIRTH Cluster of Excellence in... [more]

16 October 2014

DFG Meeting Urges for Excellence Initiative Continuation

With an urgent appeal to policy makers for a continuation of the Excellence Initiative, the largest meeting for the coordinators of the clusters of excellence, graduate schools institutional strategies has ended. The Cluster of... [more]

10 October 2014

REBIRTH researcher render safer gene vector for gene therapy

A new form of gene therapy may offer a safe and effective way to treat a severe immune deficiency that is fatal unless treated in infancy. REBIRTH researchers assisted to refine the gene therapy approach to hopefully negate the... [more]

01 September 2014

The heart valve of the future is already here

For over 15 years, a team of heart surgeons led by Professor Axel Haverich, head of the Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (HTTG) at MHH, has been working on a new procedure for biological heart... [more]

25 August 2014

Zebrafish: blood flow regulates ventricular development

During cardiac development, onset of heartbeat and blood flow occurs concurrently with the formation of the ventricles. At this stage, the heart is a tube with the muscle tissue (the myocardium) on the outside and a blood vessel... [more]

22 August 2014

Rare Lung Disease: researchers develop innovative cell therapy

A research team at Hannover Medical School (MHH) – led by Professor Gesine Hansen, director of the Department of Paediatric Pulmonology, Allergology and Neonatology, and also involved in BREATH/the German Centre for Lung Research... [more]

17 June 2014

Scientific Achievements Award for Haverich

On 17th June the Fritz-Behrens-Foundation Stiftung honoured Professor Dr. Axel Haverich with a lifetime achievement award. The scientific prize is endowed with 30,000 Euro. [more]

20 May 2014

MHH researchers identify stem cell involved in malignant blood condition

Researchers at Hannover Medical School’s (MHH) Institute of Cellular and Molecular Pathology (IZMP) and the REBIRTH Cluster of Excellence have succeeded in using a genetic marker to clearly identify cancer stem cells responsible... [more]

15 May 2014

Pre-clinical testing of engineered dendritic cells

For aggressive types of blood cancer or severe immunodeficiency defects, often only a blood stem cell transplant can provide a long-term cure. One of the main problems after stem cell transplantation is the delayed development of... [more]

10 May 2014

Heisterkamp returns

With effect from 1 February, Professor Alexander Heisterkamp accepted the post of W3 Professor of Biophotonics within the REBIRTH Cluster of Excellence. This appointment sees him move from the Friedrich Schiller University of... [more]

This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree